This feature highlights the need for better understanding of pharmacological responses and dosing for phosphodiesterase inhibitors in neonates with persistent pulmonary hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eick et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: